AI-generated content for informational purposes only. Not financial advice. Always do your own research.

About

The Allstate Corporation (NYSE: ALL) is one of the largest publicly traded personal lines property and casualty insurers in the United States, offering auto, home, and life insurance products through its extensive agent network and direct channels. The company also operates Allstate Protection Plans, a leading provider of product protection plans, and National General, which focuses on nonstandard auto insurance. Allstate is a prominent insurance stock for investors looking for exposure to the U.S. personal lines market, with a strong brand and disciplined underwriting approach.

Insurance Stocks

Allstate is a top-tier insurance stock focused primarily on personal lines property and casualty coverage, including auto and homeowners insurance. Its scale, brand recognition, and ability to adjust pricing in response to claims trends make it a core holding in the insurance stock category.

Key Financials ALL

Price $207.51
Change (1D) +0.46%
Change (30D) -0.31%
Change (60D) -0.81%
Change (90D) -0.63%
Change (180D) +1.26%
Change (1Y) +9.60%
Change (5Y) +92.35%
P/E Ratio 7.13
EPS (TTM) $29.10
52-Week Range $176.00 โ€” $216.75
50-Day MA $203.75
Volume 1.59M

Data updated Feb 15 ยท Source: Twelve Data

4.3 2 reviews

AI Reviews

๐Ÿค–
4.3 /5

Allstate is one of America's largest personal lines insurers, with dominant market share in auto and homeowners insurance. The stock presents a compelling value case with a P/E ratio of just 7.13 and robust EPS of $29.10, reflecting a strong earnings recovery after the industry-wide underwriting challenges of 2022-2023. Aggressive rate increases have restored profitability, and the company's disciplined approach to catastrophe exposure management is encouraging.

The bull case centers on continued pricing power, a hardening P&C market, and potential for multiple expansion as investors recognize the earnings normalization. The 92% five-year return demonstrates long-term wealth creation. Trading near its 50-day moving average and roughly 4% below its 52-week high suggests consolidation rather than deterioration.

Bear case risks include elevated catastrophe losses from climate-related events, potential regulatory pushback on rate increases in key states, and competitive pressure from direct writers and insurtechs. The relatively flat recent performance (essentially flat over 90 days) suggests the market may be pricing in peak earnings. Still, the low valuation and strong franchise make Allstate a solid core insurance holding.

Category Ratings

Insurance Stocks
4.3
Feb 15, 2026
AI-Generated Review Generated via Anthropic API. This is an automated evaluation, not a consumer review. Learn more
๐Ÿค–
4.3 /5

Allstate (ALL) presents a compelling value proposition within the property and casualty insurance sector, currently trading at an attractive P/E ratio of 6.91. The company has effectively navigated a difficult inflationary environment by aggressively raising premiums, a strategy that is clearly paying off as evidenced by a robust trailing EPS of $29.10. This recovery in margins demonstrates management's ability to adapt to rising claim severities and repair costs.

While the stock is trading slightly below its 50-day moving average, it remains relatively close to its 52-week high, suggesting sustained market confidence in its turnaround story. However, investors must remain cognizant of inherent risks; the insurer remains exposed to catastrophe losses from severe weather events, which introduce quarterly volatility. Furthermore, maintaining market share while pushing rate increases requires a delicate balance in a competitive landscape. Overall, Allstate stands out as a financially healthy choice for value-oriented investors seeking exposure to a recovering insurance cycle.

Category Ratings

Insurance Stocks
4.3
Feb 11, 2026
AI-Generated Review Generated via Google API. This is an automated evaluation, not a consumer review. Learn more
Allstate Screenshot

Added: Feb 10, 2026

allstate.com